The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Guardant Health(NASDAQ:GH) 
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico resear...
Website: https://guardanthealth.com/
Founded: 2013
IPO Price: $19 (Oct 04, 2018)
Full Time Employees: 1,728 (Dec 2022)
CEO / Co-Founder: Helmy Eltoukhy
Sector: Healthcare
Industry: Diagnostics & Research
Guardant Health Clinical tests
Guardant Health Biopharmaceutical tests
Guardant Health Clinical Average Selling Price
Guardant Health Clinical Average Selling Biopharmaceutical Price
Guardant Health Job openings
Guardant Health Management Fiscal Year Revenue Guidance High/Low
Guardant Health Number of Twitter Followers
Guardant Health Number of Employees (headcount)
Guardant Health Days Payable Outstanding ttm (DPO)
Guardant Health Days Receivable Outstanding ttm (DSO)
Guardant Health Days Inventory Outstanding ttm (DIO)
Guardant Health Op Cashflow Per Share ttm
Guardant Health Free Cashflow Per Share ttm
Guardant Health Cash Per Share ttm
Guardant Health P/S ratio ttm
Guardant Health (GAAP) P/E ratio ttm
Guardant Health P/B ratio ttm
No extra charts and metrics for this ticker.